Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
An Oakland woman was sentenced to five years in prison after admitting to possessing methamphetamine. Melissa Ann Wilson pleaded guilty Jan. 22 in Garrett County Circuit Court to one count of ...